Nasus Pharma Ltd. (NSRX)
NYSEAMERICAN: NSRX · Real-Time Price · USD
2.520
-0.390 (-13.40%)
Apr 29, 2026, 1:22 PM EDT - Market open
Nasus Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 30 | 83 | - | - | - |
| Enterprise Value | 30 | 85 | - | - | - |
| Last Close Price | 2.91 | 9.15 | - | - | - |
| PB Ratio | 9.48 | 29.95 | - | - | - |
| P/TBV Ratio | 12.40 | 29.95 | - | - | - |
| Debt / Equity Ratio | 0.04 | 0.04 | -0.56 | -0.65 | -0.56 |
| Net Debt / Equity Ratio | -1.51 | -1.51 | -0.47 | -0.60 | -0.51 |
| Net Debt / FCF Ratio | 0.85 | 0.85 | -2.28 | -2.20 | -1.17 |
| Quick Ratio | 1.98 | 1.98 | 0.07 | 0.05 | 0.05 |
| Current Ratio | 2.25 | 2.25 | 0.12 | 0.11 | 0.13 |
| Return on Assets (ROA) | -107.15% | -107.15% | -116.06% | -166.52% | - |
| Return on Capital Employed (ROCE) | -172.60% | -172.60% | 33.60% | 30.20% | 73.30% |
| Earnings Yield | -17.07% | -7.06% | - | - | - |
| FCF Yield | -14.37% | -5.95% | - | - | - |
| Buyback Yield / Dilution | -15.11% | -13.98% | 0.43% | -2.44% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.